209 related articles for article (PubMed ID: 32123082)
1. Structural elucidation of the
Sheedlo MJ; Anderson DM; Thomas AK; Lacy DB
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6139-6144. PubMed ID: 32123082
[No Abstract] [Full Text] [Related]
2. Structure of the cell-binding component of the
Xu X; Godoy-Ruiz R; Adipietro KA; Peralta C; Ben-Hail D; Varney KM; Cook ME; Roth BM; Wilder PT; Cleveland T; Grishaev A; Neu HM; Michel SLJ; Yu W; Beckett D; Rustandi RR; Lancaster C; Loughney JW; Kristopeit A; Christanti S; Olson JW; MacKerell AD; Georges AD; Pozharski E; Weber DJ
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1049-1058. PubMed ID: 31896582
[TBL] [Abstract][Full Text] [Related]
3. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structures of the translocational binary toxin complex CDTa-bound CDTb-pore from Clostridioides difficile.
Kawamoto A; Yamada T; Yoshida T; Sato Y; Kato T; Tsuge H
Nat Commun; 2022 Oct; 13(1):6119. PubMed ID: 36253419
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb.
Landenberger M; Nieland J; Roeder M; Nørgaard K; Papatheodorou P; Ernst K; Barth H
Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183603. PubMed ID: 33689753
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for Binding of Neutralizing Antibodies to
Goldsmith JA; Dewar V; Hermand P; Blais N; McLellan JS
J Bacteriol; 2023 Apr; 205(4):e0045622. PubMed ID: 36951574
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into the transition of Clostridioides difficile binary toxin from prepore to pore.
Anderson DM; Sheedlo MJ; Jensen JL; Lacy DB
Nat Microbiol; 2020 Jan; 5(1):102-107. PubMed ID: 31712627
[TBL] [Abstract][Full Text] [Related]
8. (1)H(N), (13)C, and (15)N resonance assignments of the CDTb-interacting domain (CDTaBID) from the Clostridium difficile binary toxin catalytic component (CDTa, residues 1-221).
Roth BM; Varney KM; Rustandi RR; Weber DJ
Biomol NMR Assign; 2016 Oct; 10(2):335-9. PubMed ID: 27351891
[TBL] [Abstract][Full Text] [Related]
9. The Importance of Therapeutically Targeting the Binary Toxin from
Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
[TBL] [Abstract][Full Text] [Related]
10. Characterization and Pharmacological Inhibition of the Pore-Forming
Ernst K; Landenberger M; Nieland J; Nørgaard K; Frick M; Fois G; Benz R; Barth H
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34071730
[TBL] [Abstract][Full Text] [Related]
11. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
Persson S; Torpdahl M; Olsen KE
Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
[TBL] [Abstract][Full Text] [Related]
12. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.
Kaiser E; Kroll C; Ernst K; Schwan C; Popoff M; Fischer G; Buchner J; Aktories K; Barth H
Infect Immun; 2011 Oct; 79(10):3913-21. PubMed ID: 21768281
[TBL] [Abstract][Full Text] [Related]
13. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196.
Perelle S; Gibert M; Bourlioux P; Corthier G; Popoff MR
Infect Immun; 1997 Apr; 65(4):1402-7. PubMed ID: 9119480
[TBL] [Abstract][Full Text] [Related]
14. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
15.
Cook ME; Varney KM; Godoy-Ruiz R; Weber DJ
Biomol NMR Assign; 2021 Apr; 15(1):35-39. PubMed ID: 33034833
[TBL] [Abstract][Full Text] [Related]
16. Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT.
Roeder M; Nestorovich EM; Karginov VA; Schwan C; Aktories K; Barth H
Toxins (Basel); 2014 Jul; 6(7):2097-114. PubMed ID: 25029374
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.
Gonçalves C; Decré D; Barbut F; Burghoffer B; Petit JC
J Clin Microbiol; 2004 May; 42(5):1933-9. PubMed ID: 15131151
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of active site residues in the enzymatic component of the
Davies AH; McGlashan J; Posner MG; Roberts AK; Shone CC; Acharya KR
Biochem Biophys Rep; 2016 Dec; 8():55-61. PubMed ID: 28955942
[No Abstract] [Full Text] [Related]
19. Clostridium difficile binary toxin CDT induces clustering of the lipolysis-stimulated lipoprotein receptor into lipid rafts.
Papatheodorou P; Hornuss D; Nölke T; Hemmasi S; Castonguay J; Picchianti M; Aktories K
mBio; 2013 Apr; 4(3):e00244-13. PubMed ID: 23631918
[TBL] [Abstract][Full Text] [Related]
20. Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.
Watanabe H; Koizumi Y; Matsumoto A; Asai N; Yamagishi Y; Mikamo H
Anaerobe; 2018 Dec; 54():140-143. PubMed ID: 30201540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
